SG Capital Management’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-12,358
Closed -$548K 58
2023
Q3
$548K Buy
+12,358
New +$574K 0.2% 45

Other funds holding IRMD

SG Capital Management's IRMD Position: Q4 2023 in Review

SG Capital Management sold out of iRadimed (IRMD) in Q4 2023, closing a stake of 12,358 shares — an estimated $548K sold.

SG Capital Management first reported a position in IRMD in Q3 2023 and held it in 1 quarter. The position peaked at $548K in Q3 2023. 119 funds tracked by Wall St. Rank hold IRMD as of Q4 2023.

  • SG Capital Management reported no remaining iRadimed position as of Q4 2023 after selling out during the quarter.
  • SG Capital Management sold 12,358 iRadimed shares in Q4 2023, an estimated $548K.
  • SG Capital Management first reported a position in iRadimed in Q3 2023 and held it in 1 quarter.
  • SG Capital Management's iRadimed position peaked at $548K in Q3 2023.
  • 119 funds tracked by Wall St. Rank held iRadimed as of Q4 2023.

Based on SG Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.